Expanded DPYD testing and the new VeriDose DPYD Panel deliver faster, more reliable insights across pharmacogenomic & oncology research.
Learn More
The VeriDose Core Panel targets the most relevant variants in 16 key genes implicated in drug metabolism pathways. It provides genotype information for 85 SNPs/INDELs recommended by leading societies for pharmacogenetics analysis (Tier 1 and Tier 2). Foundational PGx content in a single, targeted panel.
Learn MoreDate: March 25, 2026
Location: Online
Date: June 13, 2026 - June 16, 2026
Location: Gothenburg, Sweden